| The Dissolution Methods Database has been
prepared by the Division of Bioequivalence, Office of Generic Drugs,
Center for Drug Evaluation and Research, Food and Drug Administration.
The dissolution methods contained in the database are recommended
methods that are not binding on FDA or others. We will consider
alternate methods when supported by appropriate data. We recognize
that the database contains a large amount of material, and methods and
specifications may change over time. We welcome comments or suggested
changes to the database. We plan to revise the web site on an ongoing
basis. Please send suggested changes to this database, along with
supporting documentation to:
Division of Bioequivalence (HFD-650)
Office of Generic Drugs
7500 Standish Place
Rockville, MD 20855
|
